首页> 美国卫生研究院文献>Disease Markers >Epstein-Barr Virus Human Papillomavirus and Flow Cytometric Cell Cycle Kinetics in Nasopharyngeal Carcinoma and Inverted Papilloma among Egyptian Patients
【2h】

Epstein-Barr Virus Human Papillomavirus and Flow Cytometric Cell Cycle Kinetics in Nasopharyngeal Carcinoma and Inverted Papilloma among Egyptian Patients

机译:埃及患者鼻咽癌和倒置性乳头瘤中的爱泼斯坦-巴尔病毒人乳头瘤病毒和流式细胞仪细胞周期动力学

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

It is widely accepted that the Epstein-Barr virus is etiologically associated with the development of nasopharyngeal carcinoma. The human papillomavirus is also associated with inverted papilloma. We used the polymerase chain reaction technique to detect both viruses in both types of tumors. Flow cytometry was also used to study the DNA pattern and proliferative behavior of the tumors in relation to the viruses. EBV was detected in 13/20 (65%) of NPC specimens, and in none of IP (n = 10) or control specimens (n = 10). This indicates the contribution of EBV as an etiologic factor in NPC. Five cases of NPC (25%) were positive for HPV 16, two of them were EBV positive. Four HPV 16 positive cases were found among cases with inverted papilloma, but none among the control cases. Flow cytometry revealed that all NPC, IP, and control samples were diploid except one aneuploid NPC sample. Proliferative capacity (PC) of primary tumors was predictive of tumor recurrence in NPC. Using 13.6% as a cut-off point for PC, we were able to discriminate between high risk and low risk groups with 100% sensitivity and 86% specificity. PC can be used as a baseline prognostic parameter in NPC, making it possible to modify courses of treatment in an attempt to inhibit tumor recurrence.
机译:众所周知,爱泼斯坦-巴尔病毒在病因上与鼻咽癌的发展有关。人乳头瘤病毒也与倒置乳头瘤有关。我们使用聚合酶链反应技术来检测两种类型的肿瘤中的两种病毒。流式细胞仪还用于研究与病毒有关的肿瘤的DNA模式和增殖行为。在13/20(65%)的NPC标本中检出了EBV,在IP(n = 10)或对照标本(n = 10)中均未检出。这表明EBV作为NPC病因的贡献。 5例NPC的HPV 16阳性(25%),其中2例EBV阳性。在乳头状乳头状瘤倒置病例中发现4例HPV 16阳性病例,而在对照病例中未发现。流式细胞仪显示,除一个非整倍体NPC样品外,所有NPC,IP和对照样品均为二倍体。原发性肿瘤的增殖能力(PC)可预测NPC中的肿瘤复发。使用13.6%作为PC的临界值,我们能够以100%的敏感性和86%的特异性区分高危和低危人群。 PC可以用作NPC中的基线预后参数,从而可以修改治疗方案以试图抑制肿瘤复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号